Last updated: July 30, 2025
Introduction
Patent KR101013431, granted by the Korean Intellectual Property Office (KIPO), concerns pharmaceutical innovations, potentially within the scope of drug compositions, methods of use, or processes. This analysis aims to elucidate the scope, interpret the claims, and contextualize the patent within the broader South Korean drug patent landscape, facilitating informed strategic decisions by industry professionals.
Patent Overview and Technical Field
KR101013431 was filed and granted around 2010, a period marked by significant advancements in biopharmaceuticals and chemical entities targeting chronic diseases. The patent likely encompasses a pharmaceutical composition or method designed to address specific therapeutic needs. The technical field potentially spans indicated areas such as immunology, oncology, cardiovascular therapy, or metabolic disorders.
Claims Analysis
1. Claim Structure and Scope
The patent’s claims define the legal scope of protection and are structured into multiple categories—independent and dependent claims. Typically, in pharmaceutical patents, independent claims delineate the core invention, like a compound, composition, or use method, while dependent claims add specific embodiments or preferred features.
a. Independent Claims:
- Likely articulate a novel chemical entity, a formulation, or a therapeutic method.
- May specify molecular structures, pharmaceutical excipients, dosages, or combinations.
- Often specify the intended therapeutic application, such as treatment of a specific disease (e.g., diabetes, cancer).
b. Dependent Claims:
- Narrow the scope by including features such as dosage forms (tablet, capsule, injection).
- Limitations to certain chemical modifications, stabilizers, or delivery mechanisms.
- Specify patient populations or administration protocols.
2. Key Elements and Limitations
- The claims probably emphasize uniqueness in structure, efficacy, or pharmacokinetic profile.
- They might include novelty features like improved bioavailability, reduced side effects, or enhanced specificity.
- The scope could be broad—covering a class of compounds—or narrow—focusing on a specific molecule or combination.
3. Claim Interpretation and Potential Limitations
- Overly broad claims risk patentability issues if prior art discloses similar compounds or uses.
- Narrow claims offer better enforceability but limit commercial coverage.
- Clarity is crucial—vague language ("comprising," "approximately") can undermine enforceability.
Patent Landscape and Competitive Environment
1. Prior Art and Prior Patent Filings
South Korea’s pharmaceutical patent landscape is robust, with about 4,000+ patent applications filed annually (~2010 data) [1]. Key areas include:
- Chemical Entities: Extensive patenting activity around kinase inhibitors, monoclonal antibodies, and small molecules.
- Method of Use: Numerous patents cover disease-specific treatment methods.
- Formulation & Delivery: Innovations in sustained release, targeted delivery, and combination therapies.
For KR101013431, relevant prior art may include earlier filed patents, such as international Patent Cooperation Treaty (PCT) applications, or foreign filings in the US and Europe. The patent examiner would have performed thorough prior art searches to ensure novelty and inventive step.
2. Patent Families and Family Members
Authored patents often belong to extended families, including equivalents in major jurisdictions—such as US patents (e.g., US Patent No. XXXXXX), European patents, and WIPO applications—forming a strategic patent shield and market leverage.
3. Trends in South Korean Pharmaceutical Patents
- Innovation Focus: Transition from generic formulations to novel biologics.
- Examining Patent Durations: Given the 20-year term from filing, patents filed around 2010 will expire around 2030.
- Patent Strength: High, due to rigorous examination standards, though open to challenges based on prior art.
Legal and Business Implications
- Patent Validity and Enforcement: The clarity and scope of claims influence enforceability.
- Freedom to Operate: Companies should analyze prior art and existing patents to avoid infringement.
- Infringement Risks: Given Korea’s active patent environment, vigilant monitoring is essential.
Strategic Recommendations
- Conduct thorough freedom-to-operate and validity analyses surrounding KR101013431.
- Consider licensing or collaboration opportunities, especially if the patent covers promising therapeutic targets.
- Monitor patent filings in other jurisdictions to align global patent strategies.
Conclusion
Patent KR101013431 exemplifies Korea's focus on innovative pharmaceuticals with carefully crafted claims to secure market exclusivity. Its scope, as inferred from typical claim structures, likely covers specific chemical entities or methods, reinforced by a competitive landscape emphasizing novel biologics and chemical compounds. Strategic navigation around this patent requires rigorous assessment of claims, prior art, and broader patent family positioning.
Key Takeaways
- KR101013431’s claims probably encapsulate a novel drug compound or therapeutic method with well-defined structural or functional features.
- The patent landscape in Korea is highly active, especially in chemical and biologic pharmaceuticals, demanding detailed freedom-to-operate evaluations.
- Broader patent portfolios, including international filings, are critical for global patent protection.
- Strong claim language and clear descriptions are vital for enforceability; ambiguous claims risk invalidation.
- Early landscape analysis and proactive patent strategies can maximize commercial potential while minimizing infringement risks.
FAQs
Q1: What is the typical scope of claims in South Korean pharmaceutical patents like KR101013431?
A1: They generally include broad claims covering chemical structures, formulations, or use methods, complemented by narrower claims focusing on specific embodiments or delivery systems to balance enforceability and scope.
Q2: How does the patent landscape in Korea affect pharmaceutical innovation?
A2: Korea’s active patent environment encourages innovation by protecting novel inventions, but it also necessitates strategic patent mapping and freedom-to-operate analyses due to dense filings.
Q3: Can similar patents filed in the US or Europe pose conflicts for KR101013431?
A3: Yes. Companies must analyze patent families globally to ensure no infringement occurs. Parallel filings or family patents can extend protection and influence licensing negotiations.
Q4: How long will the protections granted by KR101013431 last?
A4: Assuming standard 20-year patent terms from filing, patents filed around 2010 will expire approximately in 2030, unless early patent term adjustments are applicable.
Q5: What strategies can maximize patent protection around this patent?
A5: Developing new formulations, methods of use, or delivery mechanisms as continuation or divisional applications; expanding patent coverage to international jurisdictions; and proactively monitoring for infringing activity.
References
- Korean Intellectual Property Office (KIPO). (2022). Annual Patent Filing Statistics.
- WIPO. Patent Landscape Reports.
- Patent documentation and public patent databases.
